The Competition Board  concluded the preliminary inquiry conducted in response to the application with the claim that biopharma logistics undertakings titled Biopharma Logistics Uluslararası Taşımacılık Sanayi ve Ticaret A.Ş., Transorient Uluslararası Taşımacılık ve Ticaret A.Ş. and Tunaset Biofarma Lojistik Hizmetleri A.Ş., which carry out qualified local and international door-to-door transportation services for the health sector, violated article 4 of Act no 4054 on the Protection of Competition by means of making agreements for customer allocation and imposing non-compete obligation to the allocated customers. 

After discussing the information and documents obtained and observations made in the preliminary inquiry in its meeting of 26.04.2021, the Competition Board concluded that the findings were significant and sufficient, and took the decision no 21-23/272-M to initiate an investigation about: 

• Biopharma Logistics Uluslararası Taşımacılık Sanayi ve Ticaret A.Ş.
• Transorient Uluslararası Taşımacılık ve Ticaret A.Ş.
• Tunaset Biofarma Lojistik Hizmetleri A.Ş. 

*Investigation decisions taken by the Competition Board are announced to the public following the notification of the decision to the undertakings or associations of undertakings about which an investigation has been initiated. Those announcements are made within the framework of informing the public about the decisions of the Competition Board and cannot be interpreted to mean that the undertakings or associations of undertakings about which an investigation has been initiated have violated the Act no 4054, or they are or will be subject to penal sanctions under the Act.